Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030805195> ?p ?o ?g. }
- W3030805195 endingPage "1049" @default.
- W3030805195 startingPage "1040" @default.
- W3030805195 abstract "Abstract Objective Guillain‐Barré syndrome (GBS) is a rare, life‐threatening disorder of the peripheral nervous system. Immunoglobulin G Fc‐gamma receptors (FcγRs) mediate and regulate diverse effector functions and are involved in the pathogenesis of GBS. We investigated whether the FcγR polymorphisms FcγRIIa H/R131 (rs1801274), FcγRIIIa V/F158 (rs396991), and FcγRIIIb NA1/NA2, and their haplotype patterns affect the affinity of IgG‐FcγR interactivity and influence GBS susceptibility and severity. Methods We determined FcγR polymorphisms in 303 patients with GBS and 302 ethnically matched healthy individuals from Bangladesh by allele‐specific polymerase chain reaction. Pairwise linkage disequilibrium and haplotype patterns were analyzed based on D ́statistics and the genotype package of R statistics, respectively. Logistic regression analysis and Fisher’s exact test with corrected P ( P c) values were employed for statistical comparisons. Results FcγRIIIa‐V158F was associated with the severe form of GBS compared to the mild form ( P = 0.005, OR = 2.24, 95% CI = 1.28–3.91; P c = 0.015); however, FcγR genotypes and haplotype patterns did not show any association with GBS susceptibility compared to healthy controls. FcγRIIIa‐V/V158 and FcγRIIIb‐NA2/2 were associated with recent Campylobacter jejuni infection ( P ≤ 0.001, OR = 0.36, 95% CI = 0.23–0.56; P c ≤ 0.003 and P = 0.004, OR = 1.70, 95% CI = 1.18–2.44; P c ≤ 0.012, respectively). Haplotype 1 (FcγRIIa‐H131R‐ FcγRIIIa‐V158F‐ FcγRIIIb‐NA1/2) and the FcγRIIIb‐NA2/2 genotype were more prevalent among anti‐GM1 antibody‐positive patients ( P = 0.031, OR = 9.61, 95% CI = 1.24–74.77, P c = 0.279; P = 0.027, OR = 1.62, 95% CI = 1.06–2.5, P c = 0.081, respectively). Interpretation FcγR polymorphisms and haplotypes are not associated with susceptibility to GBS, though the FcγRIIIa‐V158F genotype is associated with the severity of GBS." @default.
- W3030805195 created "2020-06-05" @default.
- W3030805195 creator A5016958104 @default.
- W3030805195 creator A5051165348 @default.
- W3030805195 creator A5084705879 @default.
- W3030805195 creator A5088344409 @default.
- W3030805195 creator A5089533715 @default.
- W3030805195 creator A5089998122 @default.
- W3030805195 date "2020-06-01" @default.
- W3030805195 modified "2023-09-27" @default.
- W3030805195 title "Fc‐gamma IIIa‐V158F receptor polymorphism contributes to the severity of Guillain‐Barré syndrome" @default.
- W3030805195 cites W1493742659 @default.
- W3030805195 cites W1530035084 @default.
- W3030805195 cites W1553963731 @default.
- W3030805195 cites W1817930542 @default.
- W3030805195 cites W1892239264 @default.
- W3030805195 cites W1967113354 @default.
- W3030805195 cites W1970147233 @default.
- W3030805195 cites W1974551350 @default.
- W3030805195 cites W1995085418 @default.
- W3030805195 cites W1997044458 @default.
- W3030805195 cites W1998268789 @default.
- W3030805195 cites W2000351827 @default.
- W3030805195 cites W2006691656 @default.
- W3030805195 cites W2014708282 @default.
- W3030805195 cites W2022258023 @default.
- W3030805195 cites W2022660570 @default.
- W3030805195 cites W2032836494 @default.
- W3030805195 cites W2033806521 @default.
- W3030805195 cites W2041482719 @default.
- W3030805195 cites W2044881757 @default.
- W3030805195 cites W2050013938 @default.
- W3030805195 cites W2055465622 @default.
- W3030805195 cites W2064309062 @default.
- W3030805195 cites W2065281901 @default.
- W3030805195 cites W2077524877 @default.
- W3030805195 cites W2081532122 @default.
- W3030805195 cites W2084748765 @default.
- W3030805195 cites W2087400492 @default.
- W3030805195 cites W2095788709 @default.
- W3030805195 cites W2099704507 @default.
- W3030805195 cites W2102753792 @default.
- W3030805195 cites W2117433429 @default.
- W3030805195 cites W2127544447 @default.
- W3030805195 cites W2138165257 @default.
- W3030805195 cites W2163089214 @default.
- W3030805195 cites W2163550872 @default.
- W3030805195 cites W2891646477 @default.
- W3030805195 cites W2970179125 @default.
- W3030805195 cites W955465506 @default.
- W3030805195 doi "https://doi.org/10.1002/acn3.51072" @default.
- W3030805195 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7317642" @default.
- W3030805195 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32484314" @default.
- W3030805195 hasPublicationYear "2020" @default.
- W3030805195 type Work @default.
- W3030805195 sameAs 3030805195 @default.
- W3030805195 citedByCount "3" @default.
- W3030805195 countsByYear W30308051952020 @default.
- W3030805195 countsByYear W30308051952022 @default.
- W3030805195 crossrefType "journal-article" @default.
- W3030805195 hasAuthorship W3030805195A5016958104 @default.
- W3030805195 hasAuthorship W3030805195A5051165348 @default.
- W3030805195 hasAuthorship W3030805195A5084705879 @default.
- W3030805195 hasAuthorship W3030805195A5088344409 @default.
- W3030805195 hasAuthorship W3030805195A5089533715 @default.
- W3030805195 hasAuthorship W3030805195A5089998122 @default.
- W3030805195 hasBestOaLocation W30308051951 @default.
- W3030805195 hasConcept C104317684 @default.
- W3030805195 hasConcept C135763542 @default.
- W3030805195 hasConcept C180754005 @default.
- W3030805195 hasConcept C197754878 @default.
- W3030805195 hasConcept C203014093 @default.
- W3030805195 hasConcept C35605836 @default.
- W3030805195 hasConcept C54355233 @default.
- W3030805195 hasConcept C71924100 @default.
- W3030805195 hasConcept C86803240 @default.
- W3030805195 hasConceptScore W3030805195C104317684 @default.
- W3030805195 hasConceptScore W3030805195C135763542 @default.
- W3030805195 hasConceptScore W3030805195C180754005 @default.
- W3030805195 hasConceptScore W3030805195C197754878 @default.
- W3030805195 hasConceptScore W3030805195C203014093 @default.
- W3030805195 hasConceptScore W3030805195C35605836 @default.
- W3030805195 hasConceptScore W3030805195C54355233 @default.
- W3030805195 hasConceptScore W3030805195C71924100 @default.
- W3030805195 hasConceptScore W3030805195C86803240 @default.
- W3030805195 hasIssue "6" @default.
- W3030805195 hasLocation W30308051951 @default.
- W3030805195 hasLocation W30308051952 @default.
- W3030805195 hasLocation W30308051953 @default.
- W3030805195 hasOpenAccess W3030805195 @default.
- W3030805195 hasPrimaryLocation W30308051951 @default.
- W3030805195 hasRelatedWork W1551477413 @default.
- W3030805195 hasRelatedWork W1989887426 @default.
- W3030805195 hasRelatedWork W1995194052 @default.
- W3030805195 hasRelatedWork W2050501127 @default.
- W3030805195 hasRelatedWork W2050778956 @default.
- W3030805195 hasRelatedWork W2051997690 @default.
- W3030805195 hasRelatedWork W2068033436 @default.